Aprea Therapeutics, Inc. (APRE)
0.91
+0.06
(+7.18%)
USD |
NASDAQ |
Mar 04, 16:00
0.9089
0.00 (0.00%)
After-Hours: 20:00
Aprea Therapeutics Cash from Investing (TTM) : 0.0004M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Modular Medical, Inc. | -3.875M |
| Ernexa Therapeutics, Inc. | -0.022M |
| Recursion Pharmaceuticals, Inc. | -16.87M |
| Tango Therapeutics, Inc. | 146.91M |
| ACADIA Pharmaceuticals, Inc. | -302.56M |